The biological vaccine sector weakened, and Watson biology fell more than 6%

Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying

The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?

SAC Releases CSR Report of Securities Firms 2022

As an important participant in the capital market, securities firms should give full play to their professional strengths and specialties, contributing to China's high-quality development.

EqualOcean Founding Partner Yuanpu Huang: Long China, a New Playbook in New Era

On November 10, Yuanpu Huang, the Founding Partner EqualOcean, was invited by China Creation Ventures (CCV) to give a speech on Long China, a New Playbook in New Era in English. He believes that Go Global will be the opportunity of the times for Chinese companies. Here we present the edited transcript.

CNMPA Approved World's First Inhaled COVID-19 Vaccine Mist

The liquid form of the vaccine is changed into an aerosol using a nebulizer. It can then be inhaled through the mouth using the nebulizer machine. According to CanSino, the vaccine can effectively induce comprehensive immune protection in response to SARS-CoV-2 after just one breath.

China Speed: Two COVID-19 Vaccines Recognized by WHO

As the second blow of the pandemic comes near the sight, China's newly-developed vaccines have been approved by the World Health Organization and available at an affordable price.